Last updated on October 2018

Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate

Brief description of study

The primary objective of this study is to evaluate the effects of filgotinib versus placebo in adults with active rheumatoid arthritis (RA) who have an inadequate response to methotrexate (MTX).

Clinical Study Identifier: NCT02889796

Contact Investigators or Research Sites near you

Start Over

Gilead Study Team

Myrtle Beach, SC United States